Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 330,117
  • Shares Outstanding, K 49,942
  • Annual Sales, $ 85,550 K
  • Annual Income, $ -113,710 K
  • 60-Month Beta 1.38
  • Price/Sales 4.07
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade FLXN with:

Options Overview

Details
  • Implied Volatility 82.19%
  • Historical Volatility 47.45%
  • IV Percentile 79%
  • IV Rank 34.63%
  • IV High 143.88% on 10/05/20
  • IV Low 49.50% on 05/28/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 27
  • Volume Avg (30-Day) 99
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 9,275
  • Open Int (30-Day) 9,100

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.50
  • Number of Estimates 4
  • High Estimate -0.49
  • Low Estimate -0.51
  • Prior Year -0.76
  • Growth Rate Est. (year over year) +34.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.23 +2.41%
on 07/19/21
9.35 -31.76%
on 06/25/21
-2.55 (-28.56%)
since 06/23/21
3-Month
6.23 +2.41%
on 07/19/21
9.73 -34.43%
on 06/16/21
-1.78 (-21.81%)
since 04/23/21
52-Week
6.23 +2.41%
on 07/19/21
14.39 -55.66%
on 07/31/20
-6.39 (-50.04%)
since 07/23/20

Most Recent Stories

More News
Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the appointment of Utpal Koppikar, Chief Financial Officer of Atara Biotherapeutics, to its Board of Directors. Mr. Koppikar will serve as the chair...

ATRA : 12.77 (-2.07%)
FLXN : 6.38 (-3.48%)
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to five new employees consisting of 20,440 restricted stock units. The Compensation Committee of the Board of Directors...

FLXN : 6.38 (-3.48%)
Pain Relief Therapeutics Market 2021 Opportunity Assessment, Business Opportunities, Top Industry Players, Trend and Growth to 2027

ABT : 120.80 (+2.16%)
ACRX : 1.2600 (-0.79%)
ACOR : 4.73 (+24.15%)
AXSM : 53.68 (-3.94%)
BAYRY : 14.9700 (-0.20%)
BDRFF : 119.7000 (-0.52%)
BDSI : 3.65 (-1.08%)
BMY : 68.34 (+0.56%)
COLL : 25.15 (+1.78%)
DEPO : 7.30 (+1.67%)
DRRX : 1.4800 (+2.07%)
EGLT : 0.0315 (-63.37%)
LLY : 244.15 (+2.37%)
FLXN : 6.38 (-3.48%)
GLPG : 59.91 (-0.33%)
HRTX : 12.89 (-1.15%)
KMPH : 10.75 (-2.18%)
MRK : 77.54 (+1.32%)
MESO : 7.26 (+1.26%)
NKTR : 16.51 (+0.79%)
NVS : 91.57 (+0.54%)
ORXOY : 4.4499 (-1.55%)
PFE : 41.68 (+0.51%)
REGN : 586.35 (-0.09%)
VRX.TO : 30.80 (-3.33%)
Flexion Therapeutics: Q1 Earnings Snapshot

BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $28.6 million in its first quarter.

FLXN : 6.38 (-3.48%)
Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Conference

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 2021 Raymond James Human...

FLXN : 6.38 (-3.48%)
Flexion Therapeutics Announces Appointment of William T. Andrews, M.D., F.A.C.P., as Chief Medical Officer

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that William T. Andrews, M.D., F.A.C.P., will join the company as Chief Medical Officer (CMO), effective July 1, 2021.

FLXN : 6.38 (-3.48%)
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to five new employees consisting of 8,510 restricted stock units. The Compensation Committee of the Board of Directors...

FLXN : 6.38 (-3.48%)
New Strong Sell Stocks for June 4th

ASLN, BLRX, FLXN, ICMB, and MRNS have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2021.

BLRX : 3.28 (-0.30%)
FLXN : 6.38 (-3.48%)
MRNS : 16.10 (-0.37%)
ASLN : 2.78 (-1.07%)
ICMB : 6.20 (+1.64%)
Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Goldman Sachs 42nd Annual...

FLXN : 6.38 (-3.48%)
Joint Pain Injections Market 2021 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report

Global Joint Pain Injections Market Size | 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape,...

AGN : 193.02 (+0.02%)
FLXN : 6.38 (-3.48%)
PFE : 41.68 (+0.51%)
SKUNF : 16.0000 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

3rd Resistance Point 7.25
2nd Resistance Point 7.03
1st Resistance Point 6.71
Last Price 6.38
1st Support Level 6.16
2nd Support Level 5.94
3rd Support Level 5.62

See More

52-Week High 14.39
Fibonacci 61.8% 11.27
Fibonacci 50% 10.31
Fibonacci 38.2% 9.35
Last Price 6.38
52-Week Low 6.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar